TriangleHEALTH PROFESSIONAL · SOURCE READING
Treatment Options for Advanced Classic HL
Source: Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: February 12, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Advanced Classic HL
Treatment options for advanced classic HL include:
Chemotherapy with or without immunotherapy or an antibody-drug conjugate.
Source links and citations
Chemotherapy with or without immunotherapy or an antibody-drug conjugate.
N-AVD (nivolumab [a checkpoint inhibitor] plus doxorubicin, vinblastine, and dacarbazine).
Chemotherapy with or without immunotherapy or an antibody-drug conjugate.
BV-AVD (brentuximab vedotin [an antibody-drug conjugate directed against CD30] plus doxorubicin, vinblastine, and dacarbazine).
Chemotherapy with or without immunotherapy or an antibody-drug conjugate.
ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine).
Continue within this section
Preserved source evidence · Not medical advice